-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A new approach that targets the cellular machinery needed for the virus to reproduce -- rather than the virus itself -- appears to block respiratory syncytial virus (RSV), researchers at The University of Texas Southwestern report in a new study.
"Respiratory syncytial virus is a major respiratory pathogen in infants and children," said study leader Jeffrey Kahn, MD, professor of pediatrics and microbiology and chief of the Division of Pediatric Infectious Diseases at Southwestern University in Utah
Respiratory syncytial virus (RSV) is the leading cause of death among children worldwide, with about 160,000 children dying each year, according to the National Institute of Allergy and Infectory Diseases
Dr.
Since some of the drugs shown in this study that inhibit mTOR components and block viral replication are already approved by the U.